These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Covalent modification of GABAA receptor isoforms by a diazepam analogue provides evidence for a novel benzodiazepine binding site that prevents modulation by these drugs. Baur R; Tan KR; Lüscher BP; Gonthier A; Goeldner M; Sigel E J Neurochem; 2008 Sep; 106(6):2353-63. PubMed ID: 18643789 [TBL] [Abstract][Full Text] [Related]
25. The value of genetic and pharmacological approaches to understanding the complexities of GABA(A) receptor subtype functions: the anxiolytic effects of benzodiazepines. Reynolds DS Pharmacol Biochem Behav; 2008 Jul; 90(1):37-42. PubMed ID: 18457867 [TBL] [Abstract][Full Text] [Related]
26. Neural and molecular mechanisms in anxiety. Wolkowitz OM; Paul SM Psychiatr Clin North Am; 1985 Mar; 8(1):145-58. PubMed ID: 2859577 [TBL] [Abstract][Full Text] [Related]
27. [Pharmacotherapy with benzodiazepines: basic principles and new developments]. Möhler H Praxis (Bern 1994); 1998 Feb; 87(6):186-90. PubMed ID: 9531812 [TBL] [Abstract][Full Text] [Related]
28. [Neurobiological approach to anxiety]. Boyer P Arch Mal Coeur Vaiss; 1987 May; 80 Spec No():43-6. PubMed ID: 2889436 [No Abstract] [Full Text] [Related]
29. [Correlation between the experimental and clinical effectiveness of benzodiazepines and their affinity for benzodiazepine receptors]. Rudenko GM; Voronina TA; Shatrova NG; Chepelev VM Biull Eksp Biol Med; 1982 Aug; 94(8):54-6. PubMed ID: 6127125 [TBL] [Abstract][Full Text] [Related]
31. New anxiolytics in development. Mosconi M; Chiamulera C; Recchia G Int J Clin Pharmacol Res; 1993; 13(6):331-44. PubMed ID: 7916335 [TBL] [Abstract][Full Text] [Related]
32. Introduction. The multiplicity of uses of benzodiazepines. Lapierre YD Can J Psychiatry; 1993 Nov; 38 Suppl 4():S101. PubMed ID: 7905779 [No Abstract] [Full Text] [Related]
33. A search for a new anticonvulsant and anxiolytic benzodiazepine devoid of side effects and tolerance liability. Costa E; Auta J; Caruncho H; Guidotti A; Impagnatiello F; Pesold C; Thompson DM Adv Biochem Psychopharmacol; 1995; 48():75-92. PubMed ID: 7653327 [No Abstract] [Full Text] [Related]
34. [A new group of anxiolytic drugs with a mechanism of action different from that of benzodiazepine derivatives]. Kostowski W; Płaźnik A Pol Tyg Lek; 1988 Dec 19-26; 43(51-52):1647-9, 1683. PubMed ID: 2908340 [No Abstract] [Full Text] [Related]
35. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Rudolph U; Crestani F; Benke D; Brünig I; Benson JA; Fritschy JM; Martin JR; Bluethmann H; Möhler H Nature; 1999 Oct; 401(6755):796-800. PubMed ID: 10548105 [TBL] [Abstract][Full Text] [Related]
36. Benzodiazepine tolerance and dependence: GABAA receptor complex locus of change. Gallager DW; Primus RJ Biochem Soc Symp; 1993; 59():135-51. PubMed ID: 7910740 [No Abstract] [Full Text] [Related]
38. Benzodiazepine, barbiturate, ethanol and hypnotic steroid hormone modulation of GABA-mediated chloride ion transport in rat brain synaptoneurosomes. Morrow AL; Suzdak PD; Paul SM Adv Biochem Psychopharmacol; 1988; 45():247-61. PubMed ID: 2902744 [No Abstract] [Full Text] [Related]
39. [The neurochemistry of anxiety (a review)]. Orlikov AB Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(11):116-20. PubMed ID: 1686952 [No Abstract] [Full Text] [Related]
40. [Benzodiazepines to people with substance abuse problems?]. Waal H; Bramness JG Tidsskr Nor Laegeforen; 2010 Mar; 130(6):610-2. PubMed ID: 20349006 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]